Negative-Pressure Ventilation in Neuromuscular Diseases in the Acute Setting.
Anna AnnunziataCecilia CalabreseFrancesca SimioliAntonietta CoppolaMartina FloraAntonella MarottaValentina Di SpiritoFrancesco DidonnaMarcellino CicaleseGiuseppe FiorentinoPublished in: Journal of clinical medicine (2022)
Mechanical ventilation started with negative-pressure ventilation (NPV) during the 1950s to assist patients with respiratory failure, secondary to poliomyelitis. Over the years, technological evolution has allowed for the development of more comfortable devices, leading to an increased interest in NPV. The patients affected by neuromuscular diseases (NMD) with chronic and acute respiratory failure (ARF) may benefit from NPV. The knowledge of the available respiratory-support techniques, indications, contraindications, and adverse effects is necessary to offer the patient a personalized treatment that considers the pathology's complexity.
Keyphrases
- respiratory failure
- mechanical ventilation
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- intensive care unit
- end stage renal disease
- newly diagnosed
- ejection fraction
- healthcare
- chronic kidney disease
- prognostic factors
- case report
- patient reported outcomes
- liver failure
- combination therapy